Many years ago the treatment of sarcoma was radiotherapy up to 2000-4000 rad. This treatment was very complicated, due to producing neoplasm after radiotherapy. By this method of treatment of osteosarcoma, the rate of survival became about 20% (two years). The second method of treatment was chemotherapy for a period of 2-5 weeks that amputation was performed afterwards. By chemotherapy, the rate of being alive reached up to 25-27% (five years). Right now, the best treatment for sarcoma is limb salvage. In our report, the chance of being alive in chondrosarcoma was about four years. This was nearly the same as that of the other institutes in the world especially in America, Europe, and Japan. The rate of recurrence was also more than that fr...
Aim: to analyze the outcome and survival rate of osteosarcoma patients in our hospital as well as th...
Survival of bone sarcoma patients has markedly improved during the last 20 years. This was followed ...
BACKGROUND: To the best of the authors' knowledge, there has been relatively little research publish...
AbstractPurposeOsteosarcoma is an aggressive malignant neoplasm, and conflicting findings have been ...
Background: Sarcomas are rare, malignant tumors of soft tissues or bone. Limb salvage surgery (LSS) ...
Purpose: Osteosarcoma is an aggressive malignant neoplasm, and conflicting findings have been report...
Current treatments for bone sarcomas include limb-salvage surgery with wide-margin resection or ampu...
Osteosarcoma is the most common primary malignant bone tumor; its standard treatment includes neoadj...
With the development of anticancer chemotherapy and improved radiographic imaging studies, limb salv...
Background Osteosarcoma is the most common primary bone sarcoma. Currently, the main treatment opti...
From the Surgical Subcommittee on behalf of the European Osteosarcoma Intergroup From the European O...
Contains fulltext : 144176.pdf (publisher's version ) (Closed access)Since the ear...
Despite multimodality limb salvage treatment (LST) for locally advanced extremity soft tissue sarcom...
BACKGROUND: Despite multimodality limb salvage treatment (LST) for locally advanced extremity soft t...
Despite multimodality limb salvage treatment (LST) for locally advanced extremity soft tissue sarcom...
Aim: to analyze the outcome and survival rate of osteosarcoma patients in our hospital as well as th...
Survival of bone sarcoma patients has markedly improved during the last 20 years. This was followed ...
BACKGROUND: To the best of the authors' knowledge, there has been relatively little research publish...
AbstractPurposeOsteosarcoma is an aggressive malignant neoplasm, and conflicting findings have been ...
Background: Sarcomas are rare, malignant tumors of soft tissues or bone. Limb salvage surgery (LSS) ...
Purpose: Osteosarcoma is an aggressive malignant neoplasm, and conflicting findings have been report...
Current treatments for bone sarcomas include limb-salvage surgery with wide-margin resection or ampu...
Osteosarcoma is the most common primary malignant bone tumor; its standard treatment includes neoadj...
With the development of anticancer chemotherapy and improved radiographic imaging studies, limb salv...
Background Osteosarcoma is the most common primary bone sarcoma. Currently, the main treatment opti...
From the Surgical Subcommittee on behalf of the European Osteosarcoma Intergroup From the European O...
Contains fulltext : 144176.pdf (publisher's version ) (Closed access)Since the ear...
Despite multimodality limb salvage treatment (LST) for locally advanced extremity soft tissue sarcom...
BACKGROUND: Despite multimodality limb salvage treatment (LST) for locally advanced extremity soft t...
Despite multimodality limb salvage treatment (LST) for locally advanced extremity soft tissue sarcom...
Aim: to analyze the outcome and survival rate of osteosarcoma patients in our hospital as well as th...
Survival of bone sarcoma patients has markedly improved during the last 20 years. This was followed ...
BACKGROUND: To the best of the authors' knowledge, there has been relatively little research publish...